Emas Pharma Limited Service company providing clinical research, pharmacovigilance, medical affairs and strategic consultancy to the pharmaceutical industry. This is a FREE LISTING on PMHUB Below are ...

ET, join Medscape for a thought-provoking Afternoon Snack Session at CMEpalooza Spring 2025, titled “Reverse Planning with ...

As deadly as the measles outbreak in west Texas and New Mexico is the spread of vaccine conspiracy theories and misinformation. According to KFF research from ...

We guarantee strategic, senior level consultancy and our stakeholder communications programmes are designed to dovetail precisely with organisational objectives. They always deliver measurable results ...

Advanced melanoma patients in England are set to be fast-tracked into a clinical trial of a new skin cancer vaccine after the NHS partnered with Oxford-based Scancell to widen access across the ...

Johnson & Johnson (J&J) has received approval from the European Commission (EC) for its subcutaneous (SC) Darzalex (daratumumab)-based quadruplet regimen in newly diagnosed multiple myeloma (MM).

Amgen has shared positive results from a late-stage study of its immunotherapy Imdelltra (tarlatamab-dlle) in small cell lung cancer (SCLC). The global DeLLphi-304 trial has been comparing the drug ...

Point.1 Synthesis: smarter omni-channel planning to avoid wastage And lastly, we have Point.1 Synthesis, a product to aid brand experience activation. Synthesis uses Point.1 data touchpoint usage, ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been approved by the US Food and Drug ...

AstraZeneca’s (AZ) AKT inhibitor Truqap (capivasertib) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a combination treatment for advanced breast ...

Roche’s Columvi (glofitamab) has been approved by the European Commission (EC) as part of a combination treatment for diffuse ...

Equipping patients, carers and loved ones with the tools and understanding to make the choices that are right for them ...